0001579428-14-000001.txt : 20140923 0001579428-14-000001.hdr.sgml : 20140923 20140923102804 ACCESSION NUMBER: 0001579428-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140923 DATE AS OF CHANGE: 20140923 EFFECTIVENESS DATE: 20140923 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Axsome Therapeutics, Inc. CENTRAL INDEX KEY: 0001579428 IRS NUMBER: 454241907 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-225142 FILM NUMBER: 141115322 BUSINESS ADDRESS: STREET 1: 45 ROCKEFELLER PLAZA, SUITE 2000 CITY: NEW YORK STATE: NY ZIP: 10111 BUSINESS PHONE: 212-203-5072 MAIL ADDRESS: STREET 1: 45 ROCKEFELLER PLAZA, SUITE 2000 CITY: NEW YORK STATE: NY ZIP: 10111 D 1 primary_doc.xml X0707 D LIVE 0001579428 Axsome Therapeutics, Inc. 45 ROCKEFELLER PLAZA, SUITE 2000 NEW YORK NY NEW YORK 10111 212-203-5072 DELAWARE None None Corporation true 2012 Herriot Tabuteau 45 Rockefeller Plaza, Suite 2000 New York NY NEW YORK 10111 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false 2014-09-09 false true true false 25000 Brookline Group, LLC 153587 None None 2501 Twentieth Place South Suite 275 Birmingham AL ALABAMA 35223 AL ALABAMA AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT DC DISTRICT OF COLUMBIA FL FLORIDA IL ILLINOIS IA IOWA MD MARYLAND MA MASSACHUSETTS MS MISSISSIPPI MO MISSOURI NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA TX TEXAS WI WISCONSIN true 7500000 2025000 5475000 false 12 500000 true 0 Commissions are based on a percentage. This is the maximum amount payable assuming full amount of offering is sold. Commission includes warrants in addition to cash payment. 0 false Axsome Therapeutics, Inc. Herriot Tabuteau Herriot Tabuteau Chief Executive Officer 2014-09-19